Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Metformin reduces certain hormone levels in men with early-onset hair loss.

PCOS is a common hormonal disorder in women linked to several health risks and can be managed through various treatments.

The document concludes that managing PCOS effectively requires considering ethnic differences, obesity's impact, and ethical concerns in treatment approaches.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Most women with hirsutism in the UAE have polycystic ovary syndrome (PCOS).

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

These ovarian conditions cause high testosterone levels.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

High doses of finasteride cause cell growth and tumors in mice.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.